A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia

Completed · Phase 3

Conditions studied: Iron Deficiency Anemia

In brief

To evaluate the safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia (IDA).

Key facts

Study ID
NCT01114217
Run by
AMAG Pharmaceuticals, Inc.
People needed
634
Starts
2010-07-27
Expected to finish
2013-04-23
Last updated by the study team
2022-04-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.